Patents Assigned to EaglePharma Pty Ltd
  • Publication number: 20170304351
    Abstract: The invention relates to methods, uses and compositions for treating non-infectious diseases with a therapeutically effective amount of a pharmaceutical composition comprising methylsulfonylmethane, glucosamine, L-glycine, and vitamin B12 (or a derivative of any one thereof).
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Applicant: EaglePharma Pty Ltd
    Inventor: Paul TURNER
  • Patent number: 9387218
    Abstract: The invention relates to the treatment of an inflammatory or immune disorder with a pharmaceutical composition including methylsulphonylmethane, glucosamine and glycine or pharmaceutically acceptable salts or derivatives of these compounds.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: July 12, 2016
    Assignee: EAGLEPHARMA PTY LTD
    Inventor: Paul Frederick Turner
  • Publication number: 20130281401
    Abstract: The invention relates to methods, uses and compositions for treating non-infectious diseases with a therapeutically effective amount of a pharmaceutical composition comprising methylsulfonylmethane, glucosamine, L-glycine, and vitamin B12 (or a derivative of any one thereof).
    Type: Application
    Filed: October 5, 2011
    Publication date: October 24, 2013
    Applicant: EaglePharma Pty Ltd
    Inventor: Paul Turner